Target- |
Mechanism- |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date25 Jan 1971 |
评价新型口服葡萄糖溶液相较于已上市口服葡萄糖粉剂用于糖耐量检查的准确性、安全性及患者偏好度的随机、双盲、交叉试验
[Translation] A randomized, double-blind, crossover trial evaluating the accuracy, safety, and patient preference of a novel oral glucose solution compared to existing oral glucose powders for glucose tolerance testing.
主要目的:评价新型口服葡萄糖溶液与葡萄糖粉剂用于OGTT检查结果的一致性。次要目的:1) 比较受试者对两种葡萄糖制剂的偏好度;2) 评价新型口服葡萄糖溶液及已上市口服葡萄糖粉剂用于糖耐量检查的安全性、耐受性。3) 评价不同葡萄糖制剂对受试者血浆葡萄糖、胰岛素和 C 肽浓度的影响。
[Translation] Primary objective: To evaluate the consistency of results between a novel oral glucose solution and glucose powder for oral glucose tolerance tests (OGTT). Secondary objectives: 1) To compare subjects' preferences for the two glucose formulations; 2) To evaluate the safety and tolerability of the novel oral glucose solution and the marketed oral glucose powder for glucose tolerance tests; 3) To evaluate the effects of different glucose formulations on subjects' plasma glucose, insulin, and C-peptide concentrations.
天龙通络胶囊治疗中风恢复期的有效性及安全性的随机、双盲、阳性药、安慰剂平行对照、多中心临床试验
[Translation] A randomized, double-blind, active-drug, placebo-controlled, multicenter clinical trial on the efficacy and safety of Tianlong Tongluo Capsule in the treatment of stroke recovery
初步评价天龙通络胶囊治疗中风恢复期(中经络.风痰瘀阻证)的有效性及安全性
[Translation] Preliminary evaluation of the effectiveness and safety of Tianlong Tongluo Capsule in the treatment of stroke recovery (middle meridian, wind, phlegm and blood stasis syndrome)
100 Clinical Results associated with Beijing Golden Tang Medicine Science & Technology Development Co., Ltd.
0 Patents (Medical) associated with Beijing Golden Tang Medicine Science & Technology Development Co., Ltd.
100 Deals associated with Beijing Golden Tang Medicine Science & Technology Development Co., Ltd.
100 Translational Medicine associated with Beijing Golden Tang Medicine Science & Technology Development Co., Ltd.